poh has a new board, page-60

About bloody time - they took long enough to ring in these changes. To me, the old board were the oversee'rs to poor corporate governance practices, measures and controls. This is a good move but boy it took them a while but the lineup has improved lets just hope they don't sit on their arses for another 2-3years and let (ironically) criminals in the ARSEGATE saga get away with such things.

My main issue with POH is not with the product or the applications but that the board focus on the pain patch while different fragmentations of the company are utilising the TPM product throughout other applications and those focuses are kicking goals but the board are last to know and don't show much interest in them hence the marketing and the SP drops.

We need the new board to focus on more than just the pain patch - they need to outwardly market POH-thru the TPM technology product and pay attention to all the different applications no matter what the incentives. Knowing full well the pain patch will be successful is one thing but backing the key ingredient and process through strategic marketing embraces all its current and future applications.

Based on the slowness of the Oxy patches development the focus on the other applications of TPM can provide pain relief in these slower periods both for the company and SHers.

I think the share price this time next year will look very different indeed but then again I've said that before!
C'mon new board members - embrace the technology not one application and remove those rose coloured glasses so the full value of POH can come to life. Luck all :)

PS - A new company presentation should be held at the next major conference focussing on the product and all its applications IMO.